Wellbutrin SR® 150 mg Extended-Release Tablet, single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

CompletedNCT00865371

Actavis Inc.Healthy

Start: 2004-09-30End: 2004-09-30Updated: 2010-08-16

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

CompletedNCT00865410

Actavis Inc.Healthy

Start: 2004-08-31End: 2004-09-30Updated: 2010-08-16